Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
This article evaluates which allocation—S&P 500 or Total Market—better supports retirement goals, with actionable insights for allocators.
28,550 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
A Dutch court halted a welfare-detection AI system over privacy and bias concerns, prompting watchdogs to weigh tight...
Sellers turning to private listings may avoid public exposure, but new data suggests this approach can lead to lower ...
As 2026 unfolds, Tesla and BYD are diverging on growth bets. This article weighs earnings, margins, and software stra...
As deal talk returns to tech, we weigh Reddit, Roku, and SoundHound AI for takeover potential. None has a confirmed b...
The U.S. power grid isn’t a single machine. It’s three interconnections that rarely move power across regions, a flaw...
A routine Facebook scroll turned into a near-financial trap when a stranger intervened before a payment could go thro...
Global markets weigh climate risk as a likely Super El Niño could boost temperatures in 2027. This stock trader’s gui...
When a public tribute shines a light on mentors and fathers, it offers more than sentiment—it's a blueprint for famil...
Caregiving and end-of-life decisions test both hearts and wallets. This article explores practical, compassionate ste...
When a child faces a serious health challenge, finances can quickly become overwhelming. This guide offers clear, act...
Public moments can shift finances as quickly as headlines change. This article uses adele’s rare return sparks as a s...